Groupama Asset Managment Reduces Stock Holdings in Cardinal Health, Inc. $CAH

Groupama Asset Managment decreased its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 75.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,037 shares of the company’s stock after selling 9,198 shares during the period. Groupama Asset Managment’s holdings in Cardinal Health were worth $624,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in CAH. Vanguard Group Inc. grew its stake in shares of Cardinal Health by 2.0% in the 4th quarter. Vanguard Group Inc. now owns 31,441,258 shares of the company’s stock worth $6,461,179,000 after buying an additional 617,775 shares during the last quarter. State Street Corp grew its stake in shares of Cardinal Health by 1.8% in the fourth quarter. State Street Corp now owns 12,509,230 shares of the company’s stock worth $2,570,647,000 after acquiring an additional 221,497 shares during the period. Geode Capital Management LLC grew its position in Cardinal Health by 0.7% in the 4th quarter. Geode Capital Management LLC now owns 6,529,013 shares of the company’s stock worth $1,336,750,000 after purchasing an additional 43,924 shares during the period. Wellington Management Group LLP grew its holdings in shares of Cardinal Health by 153.2% in the third quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock worth $911,010,000 after acquiring an additional 3,511,579 shares during the period. Finally, Norges Bank bought a new stake in shares of Cardinal Health during the 4th quarter valued at about $790,344,000. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Stock Up 0.1%

Shares of CAH stock opened at $222.08 on Friday. The firm has a market cap of $52.01 billion, a price-to-earnings ratio of 33.96, a PEG ratio of 1.21 and a beta of 0.52. Cardinal Health, Inc. has a 52-week low of $137.75 and a 52-week high of $233.60. The company’s 50 day moving average is $204.34 and its 200 day moving average is $209.27.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, April 30th. The company reported $3.17 EPS for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The company had revenue of $60.94 billion during the quarter, compared to analysts’ expectations of $62.10 billion. During the same quarter in the prior year, the company posted $2.35 earnings per share. Cardinal Health’s revenue for the quarter was up 11.0% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Analysts anticipate that Cardinal Health, Inc. will post 10.76 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be issued a dividend of $0.5158 per share. This represents a $2.06 dividend on an annualized basis and a dividend yield of 0.9%. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Wednesday, July 1st. Cardinal Health’s dividend payout ratio is presently 31.19%.

Wall Street Analyst Weigh In

CAH has been the subject of several recent research reports. Leerink Partners reissued an “outperform” rating and set a $275.00 price target on shares of Cardinal Health in a report on Monday, March 9th. Evercore cut their target price on shares of Cardinal Health from $260.00 to $240.00 and set an “outperform” rating for the company in a research note on Wednesday, April 8th. TD Cowen raised their price target on Cardinal Health from $251.00 to $255.00 and gave the company a “buy” rating in a report on Friday, May 1st. JPMorgan Chase & Co. reduced their target price on shares of Cardinal Health from $243.00 to $215.00 and set a “neutral” rating on the stock in a report on Monday, May 4th. Finally, Citigroup cut their target price on Cardinal Health from $249.00 to $245.00 and set a “buy” rating on the stock in a research report on Friday, May 1st. Fourteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $246.93.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.